NIH-funded research R01 grant

GIRK potassium channels and heart rhythm in aging and platelet function

Official title: Structural Determinants of PIP2 Regulation

Funded at Northeastern University · NIH-11384323 · Data updated 2026-11-12

A study focused on how specific heart and blood vessel channels (GIRK) influence heart rate, heart-rate variability, and clotting risk as people age.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNortheastern University
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 1998
Project endMay 31, 2028
Funding year2026
Award (this year)$683,447
NIH project number5R01HL059949-29
Project IDNIH-11384323 on NIH RePORTER

Who could benefit from this research

Could help

Adults with atrial fibrillation or at risk of Afib, and individuals undergoing treatment for arrhythmias.

Less likely to help

People without heart rhythm issues or those not at risk for Afib are less likely to benefit.

What this research studies

This project looks at GIRK channels, which help control heart rate and heart-rate variability, and explores how aging changes their activity to increase atrial fibrillation risk. Researchers aim to understand how aging-related oxidative stress activates PKC to modify GIRK4 channels and raise mortality and stroke risk. The work also considers why current antiarrhythmic drugs can affect the ventricles and seeks atria-specific inhibitors that preserve normal heart rhythm. Additionally, the study touches on how GIRK channels in platelets participate in thrombus formation during vascular injury. Overall, the project integrates molecular insights with potential implications for safer, more targeted therapies for atrial fibrillation and related cardiovascular issues.

Why it matters

Potential benefit: If successful, this research could lead to safer, more precise treatments for atrial fibrillation and better strategies to protect heart health in aging adults.

How similar studies have gone: Prior work has shown that targeted modulation of GIRK activity can influence atrial-specific effects, but selective atrial inhibitors remain a challenge.

Where this research is happening

  • Northeastern University
    Boston, United States
    Active

Researchers

  • Principal investigator: Plant, Leigh Daniel — Northeastern University
  • Study coordinator: Plant, Leigh Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.